Pretty pointless promoting Vitrogrow as a product for sale in a region that doesn't have approval yet.
Yes, I do appreciate that people from all over the world will come to the conference, but a conference based in Boston is likely to be predominantly North American doctors wouldn't you say? It comes across as a bit haphazard in my opinion to promote something as a product for sale when approvals aren't yet in place. So the best thing to do is discuss the science behind the product and the technical merits and trial outcomes.
TIS Price at posting:
44.0¢ Sentiment: Hold Disclosure: Held